Rare Pediatric Disease (RPD) Priority Review Voucher (PRV): Key Updates
Video Summary
On September 30, 2024 the Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) program had effectively sunset and could no longer issue new vouchers due to prior statutory expiration. Here to explain the purpose of the RPD Priority Review Voucher (PRV) program, recent reauthorisation and key updates is Dr Susan McCune, formerly the Chief Pediatrician at the FDA.